nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—CA2—osteoporosis	0.536	1	CbGaD
Dobutamine—COMT—Conjugated Estrogens—osteoporosis	0.234	0.573	CbGbCtD
Dobutamine—CA2—Zoledronate—osteoporosis	0.174	0.427	CbGbCtD
Dobutamine—Masoprocol—CYP19A1—osteoporosis	0.000839	1	CrCbGaD
Dobutamine—Phlebitis—Pamidronate—osteoporosis	0.000821	0.0308	CcSEcCtD
Dobutamine—Hypotension—Calcium Acetate—osteoporosis	0.000761	0.0285	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Estradiol—osteoporosis	0.000759	0.0285	CcSEcCtD
Dobutamine—Phlebitis—Conjugated Estrogens—osteoporosis	0.000722	0.0271	CcSEcCtD
Dobutamine—Skin exfoliation—Estradiol—osteoporosis	0.000655	0.0245	CcSEcCtD
Dobutamine—Hypokalaemia—Pamidronate—osteoporosis	0.000644	0.0241	CcSEcCtD
Dobutamine—Angina pectoris—Risedronate—osteoporosis	0.000626	0.0235	CcSEcCtD
Dobutamine—Hypokalaemia—Zoledronate—osteoporosis	0.000588	0.022	CcSEcCtD
Dobutamine—Phlebitis—Estradiol—osteoporosis	0.000578	0.0217	CcSEcCtD
Dobutamine—Pruritus—Calcium Acetate—osteoporosis	0.000576	0.0216	CcSEcCtD
Dobutamine—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.000566	0.0212	CcSEcCtD
Dobutamine—Palpitations—Estropipate—osteoporosis	0.000501	0.0188	CcSEcCtD
Dobutamine—Nausea—Calcium Acetate—osteoporosis	0.000484	0.0181	CcSEcCtD
Dobutamine—Palpitations—Ibandronate—osteoporosis	0.00048	0.018	CcSEcCtD
Dobutamine—Chest pain—Alendronate—osteoporosis	0.000475	0.0178	CcSEcCtD
Dobutamine—Chest pain—Raloxifene—osteoporosis	0.000468	0.0175	CcSEcCtD
Dobutamine—Chest pain—Ibandronate—osteoporosis	0.000463	0.0173	CcSEcCtD
Dobutamine—Chest pain—Calcitriol—osteoporosis	0.000453	0.017	CcSEcCtD
Dobutamine—Thrombocytopenia—Raloxifene—osteoporosis	0.000439	0.0164	CcSEcCtD
Dobutamine—Nausea—Ergocalciferol—osteoporosis	0.000427	0.016	CcSEcCtD
Dobutamine—Chest pain—Risedronate—osteoporosis	0.000381	0.0143	CcSEcCtD
Dobutamine—Pruritus—Etidronic acid—osteoporosis	0.000378	0.0142	CcSEcCtD
Dobutamine—Palpitations—Zoledronate—osteoporosis	0.000344	0.0129	CcSEcCtD
Dobutamine—Thrombocytopenia—Pamidronate—osteoporosis	0.00034	0.0128	CcSEcCtD
Dobutamine—ADRB1—G alpha (s) signalling events—CALCR—osteoporosis	0.000339	0.0123	CbGpPWpGaD
Dobutamine—ADRB1—G alpha (s) signalling events—PTH1R—osteoporosis	0.000339	0.0123	CbGpPWpGaD
Dobutamine—Tachycardia—Pamidronate—osteoporosis	0.000339	0.0127	CcSEcCtD
Dobutamine—Headache—Etidronic acid—osteoporosis	0.000335	0.0126	CcSEcCtD
Dobutamine—ADRB2—G alpha (s) signalling events—CALCR—osteoporosis	0.000332	0.012	CbGpPWpGaD
Dobutamine—ADRB2—G alpha (s) signalling events—PTH1R—osteoporosis	0.000332	0.012	CbGpPWpGaD
Dobutamine—Chest pain—Zoledronate—osteoporosis	0.000331	0.0124	CcSEcCtD
Dobutamine—Palpitations—Conjugated Estrogens—osteoporosis	0.000331	0.0124	CcSEcCtD
Dobutamine—Pruritus—Estropipate—osteoporosis	0.000327	0.0123	CcSEcCtD
Dobutamine—Dyspnoea—Risedronate—osteoporosis	0.000326	0.0122	CcSEcCtD
Dobutamine—Hypotension—Pamidronate—osteoporosis	0.000325	0.0122	CcSEcCtD
Dobutamine—Pruritus—Alendronate—osteoporosis	0.000322	0.0121	CcSEcCtD
Dobutamine—Chest pain—Conjugated Estrogens—osteoporosis	0.000319	0.012	CcSEcCtD
Dobutamine—Nausea—Etidronic acid—osteoporosis	0.000318	0.0119	CcSEcCtD
Dobutamine—Pruritus—Ibandronate—osteoporosis	0.000314	0.0118	CcSEcCtD
Dobutamine—COMT—Biological oxidations—CYP27A1—osteoporosis	0.000314	0.0114	CbGpPWpGaD
Dobutamine—Thrombocytopenia—Zoledronate—osteoporosis	0.000311	0.0117	CcSEcCtD
Dobutamine—Dyspnoea—Pamidronate—osteoporosis	0.00031	0.0116	CcSEcCtD
Dobutamine—Tachycardia—Zoledronate—osteoporosis	0.00031	0.0116	CcSEcCtD
Dobutamine—COMT—Metapathway biotransformation—CYP27A1—osteoporosis	0.000309	0.0112	CbGpPWpGaD
Dobutamine—Pruritus—Calcitriol—osteoporosis	0.000307	0.0115	CcSEcCtD
Dobutamine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000298	0.0112	CcSEcCtD
Dobutamine—Hypotension—Zoledronate—osteoporosis	0.000297	0.0111	CcSEcCtD
Dobutamine—Headache—Estropipate—osteoporosis	0.00029	0.0109	CcSEcCtD
Dobutamine—Hypotension—Conjugated Estrogens—osteoporosis	0.000286	0.0107	CcSEcCtD
Dobutamine—Headache—Alendronate—osteoporosis	0.000285	0.0107	CcSEcCtD
Dobutamine—Dyspnoea—Zoledronate—osteoporosis	0.000283	0.0106	CcSEcCtD
Dobutamine—Headache—Raloxifene—osteoporosis	0.000281	0.0105	CcSEcCtD
Dobutamine—Headache—Ibandronate—osteoporosis	0.000278	0.0104	CcSEcCtD
Dobutamine—Nausea—Estropipate—osteoporosis	0.000275	0.0103	CcSEcCtD
Dobutamine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000273	0.0102	CcSEcCtD
Dobutamine—Headache—Calcitriol—osteoporosis	0.000272	0.0102	CcSEcCtD
Dobutamine—Nausea—Alendronate—osteoporosis	0.000271	0.0101	CcSEcCtD
Dobutamine—Nausea—Raloxifene—osteoporosis	0.000266	0.00998	CcSEcCtD
Dobutamine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000265	0.00995	CcSEcCtD
Dobutamine—Palpitations—Estradiol—osteoporosis	0.000265	0.00993	CcSEcCtD
Dobutamine—Nausea—Ibandronate—osteoporosis	0.000264	0.00988	CcSEcCtD
Dobutamine—Pruritus—Risedronate—osteoporosis	0.000259	0.0097	CcSEcCtD
Dobutamine—Nausea—Calcitriol—osteoporosis	0.000258	0.00967	CcSEcCtD
Dobutamine—Chest pain—Estradiol—osteoporosis	0.000255	0.00957	CcSEcCtD
Dobutamine—Pruritus—Pamidronate—osteoporosis	0.000246	0.00922	CcSEcCtD
Dobutamine—Tachycardia—Estradiol—osteoporosis	0.000239	0.00895	CcSEcCtD
Dobutamine—Headache—Ethinyl Estradiol—osteoporosis	0.000235	0.00881	CcSEcCtD
Dobutamine—Headache—Risedronate—osteoporosis	0.000229	0.00859	CcSEcCtD
Dobutamine—Pruritus—Zoledronate—osteoporosis	0.000225	0.00842	CcSEcCtD
Dobutamine—Nausea—Ethinyl Estradiol—osteoporosis	0.000223	0.00835	CcSEcCtD
Dobutamine—Dyspnoea—Estradiol—osteoporosis	0.000218	0.00818	CcSEcCtD
Dobutamine—Headache—Pamidronate—osteoporosis	0.000218	0.00816	CcSEcCtD
Dobutamine—Nausea—Risedronate—osteoporosis	0.000217	0.00814	CcSEcCtD
Dobutamine—Pruritus—Conjugated Estrogens—osteoporosis	0.000216	0.00811	CcSEcCtD
Dobutamine—Nausea—Pamidronate—osteoporosis	0.000206	0.00774	CcSEcCtD
Dobutamine—Headache—Zoledronate—osteoporosis	0.000199	0.00746	CcSEcCtD
Dobutamine—Headache—Conjugated Estrogens—osteoporosis	0.000192	0.00718	CcSEcCtD
Dobutamine—Nausea—Zoledronate—osteoporosis	0.000189	0.00707	CcSEcCtD
Dobutamine—Nausea—Conjugated Estrogens—osteoporosis	0.000182	0.00681	CcSEcCtD
Dobutamine—ADRB1—G alpha (s) signalling events—PTH—osteoporosis	0.000178	0.00647	CbGpPWpGaD
Dobutamine—ADRB2—G alpha (s) signalling events—PTH—osteoporosis	0.000174	0.00633	CbGpPWpGaD
Dobutamine—Pruritus—Estradiol—osteoporosis	0.000173	0.00649	CcSEcCtD
Dobutamine—CA5A—Metabolism—FDPS—osteoporosis	0.000169	0.00612	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PKM—osteoporosis	0.000169	0.00612	CbGpPWpGaD
Dobutamine—COMT—Biological oxidations—CYP19A1—osteoporosis	0.000165	0.00598	CbGpPWpGaD
Dobutamine—COMT—Metapathway biotransformation—CYP19A1—osteoporosis	0.000163	0.0059	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PGLS—osteoporosis	0.00016	0.0058	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GPD2—osteoporosis	0.00016	0.0058	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PKM—osteoporosis	0.000157	0.00571	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—FDPS—osteoporosis	0.000157	0.00571	CbGpPWpGaD
Dobutamine—Headache—Estradiol—osteoporosis	0.000153	0.00575	CcSEcCtD
Dobutamine—CA5B—Metabolism—GPD2—osteoporosis	0.000149	0.00542	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PGLS—osteoporosis	0.000149	0.00542	CbGpPWpGaD
Dobutamine—ADRB1—G alpha (s) signalling events—PTHLH—osteoporosis	0.000148	0.00536	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ATIC—osteoporosis	0.000146	0.00531	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PNP—osteoporosis	0.000146	0.00531	CbGpPWpGaD
Dobutamine—Nausea—Estradiol—osteoporosis	0.000145	0.00545	CcSEcCtD
Dobutamine—ADRB2—G alpha (s) signalling events—PTHLH—osteoporosis	0.000144	0.00524	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PNP—osteoporosis	0.000136	0.00495	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ATIC—osteoporosis	0.000136	0.00495	CbGpPWpGaD
Dobutamine—ADRB1—G alpha (s) signalling events—CALCA—osteoporosis	0.00013	0.00472	CbGpPWpGaD
Dobutamine—ADRB2—G alpha (s) signalling events—CALCA—osteoporosis	0.000127	0.00462	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—OXCT1—osteoporosis	0.000124	0.00451	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CA2—osteoporosis	0.000124	0.00451	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CALCR—osteoporosis	0.000123	0.00447	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—PTH1R—osteoporosis	0.000123	0.00447	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—MGLL—osteoporosis	0.000121	0.0044	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CALCR—osteoporosis	0.000121	0.00437	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—PTH1R—osteoporosis	0.000121	0.00437	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000119	0.00433	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—OXCT1—osteoporosis	0.000116	0.00421	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CA2—osteoporosis	0.000116	0.00421	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—MGLL—osteoporosis	0.000113	0.0041	CbGpPWpGaD
Dobutamine—CA2—Metabolism—FDPS—osteoporosis	0.000111	0.00405	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PKM—osteoporosis	0.000111	0.00405	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GPD2—osteoporosis	0.000106	0.00384	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PGLS—osteoporosis	0.000106	0.00384	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—IDH2—osteoporosis	0.000103	0.00374	CbGpPWpGaD
Dobutamine—COMT—Biological oxidations—POMC—osteoporosis	9.91e-05	0.0036	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CYP27A1—osteoporosis	9.68e-05	0.00351	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	9.67e-05	0.00351	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ATIC—osteoporosis	9.67e-05	0.00351	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PNP—osteoporosis	9.67e-05	0.00351	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—IDH2—osteoporosis	9.62e-05	0.00349	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	9.46e-05	0.00343	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ACP5—osteoporosis	9.42e-05	0.00342	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PKM—osteoporosis	9.34e-05	0.00339	CbGpPWpGaD
Dobutamine—COMT—Metabolism—FDPS—osteoporosis	9.34e-05	0.00339	CbGpPWpGaD
Dobutamine—ADRB1—G alpha (s) signalling events—ADCY5—osteoporosis	9.25e-05	0.00336	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—ADCY5—osteoporosis	9.15e-05	0.00332	CbGpPWpGaD
Dobutamine—ADRB2—G alpha (s) signalling events—ADCY5—osteoporosis	9.05e-05	0.00328	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CYP27A1—osteoporosis	9.04e-05	0.00328	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GPD2—osteoporosis	8.86e-05	0.00321	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PGLS—osteoporosis	8.86e-05	0.00321	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ACP5—osteoporosis	8.79e-05	0.00319	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—TPI1—osteoporosis	8.76e-05	0.00318	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	8.28e-05	0.00301	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—P4HB—osteoporosis	8.23e-05	0.00299	CbGpPWpGaD
Dobutamine—CA2—Metabolism—OXCT1—osteoporosis	8.22e-05	0.00298	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—TPI1—osteoporosis	8.18e-05	0.00297	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	8.1e-05	0.00294	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ATIC—osteoporosis	8.1e-05	0.00294	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PNP—osteoporosis	8.1e-05	0.00294	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GAPDH—osteoporosis	8.08e-05	0.00293	CbGpPWpGaD
Dobutamine—CA2—Metabolism—MGLL—osteoporosis	8.01e-05	0.00291	CbGpPWpGaD
Dobutamine—ADRB1—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	7.99e-05	0.0029	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—RAP1A—osteoporosis	7.87e-05	0.00286	CbGpPWpGaD
Dobutamine—ADRB2—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	7.81e-05	0.00284	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—P4HB—osteoporosis	7.69e-05	0.00279	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GAPDH—osteoporosis	7.55e-05	0.00274	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—RAP1A—osteoporosis	7.35e-05	0.00267	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CALCR—osteoporosis	6.96e-05	0.00253	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PTH1R—osteoporosis	6.96e-05	0.00253	CbGpPWpGaD
Dobutamine—COMT—Metabolism—OXCT1—osteoporosis	6.89e-05	0.0025	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CA2—osteoporosis	6.89e-05	0.0025	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CALCR—osteoporosis	6.81e-05	0.00247	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PTH1R—osteoporosis	6.81e-05	0.00247	CbGpPWpGaD
Dobutamine—CA2—Metabolism—IDH2—osteoporosis	6.81e-05	0.00247	CbGpPWpGaD
Dobutamine—ADRB1—G alpha (s) signalling events—POMC—osteoporosis	6.8e-05	0.00247	CbGpPWpGaD
Dobutamine—COMT—Metabolism—MGLL—osteoporosis	6.71e-05	0.00244	CbGpPWpGaD
Dobutamine—ADRB2—G alpha (s) signalling events—POMC—osteoporosis	6.66e-05	0.00242	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—PTH—osteoporosis	6.47e-05	0.00235	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CYP27A1—osteoporosis	6.4e-05	0.00232	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ENO1—osteoporosis	6.36e-05	0.00231	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—PTH—osteoporosis	6.33e-05	0.0023	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CALCR—osteoporosis	6.32e-05	0.00229	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PTH1R—osteoporosis	6.32e-05	0.00229	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CNR2—osteoporosis	6.31e-05	0.00229	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PSMA2—osteoporosis	6.27e-05	0.00228	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PSMA5—osteoporosis	6.27e-05	0.00228	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ACP5—osteoporosis	6.23e-05	0.00226	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CALCR—osteoporosis	6.18e-05	0.00224	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PTH1R—osteoporosis	6.18e-05	0.00224	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CNR2—osteoporosis	6.17e-05	0.00224	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ENO1—osteoporosis	5.94e-05	0.00216	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—WNT1—osteoporosis	5.93e-05	0.00215	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PSMA5—osteoporosis	5.85e-05	0.00212	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PSMA2—osteoporosis	5.85e-05	0.00212	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—WNT1—osteoporosis	5.8e-05	0.00211	CbGpPWpGaD
Dobutamine—CA2—Metabolism—TPI1—osteoporosis	5.79e-05	0.0021	CbGpPWpGaD
Dobutamine—COMT—Metabolism—IDH2—osteoporosis	5.71e-05	0.00207	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—MGLL—osteoporosis	5.53e-05	0.00201	CbGpPWpGaD
Dobutamine—CA2—Metabolism—P4HB—osteoporosis	5.44e-05	0.00198	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—MGLL—osteoporosis	5.41e-05	0.00196	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYP27A1—osteoporosis	5.37e-05	0.00195	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—PTHLH—osteoporosis	5.36e-05	0.00195	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GAPDH—osteoporosis	5.34e-05	0.00194	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—PTHLH—osteoporosis	5.25e-05	0.0019	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ACP5—osteoporosis	5.22e-05	0.00189	CbGpPWpGaD
Dobutamine—CA2—Metabolism—RAP1A—osteoporosis	5.21e-05	0.00189	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CYP19A1—osteoporosis	5.09e-05	0.00185	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—MGLL—osteoporosis	5.02e-05	0.00182	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—MGLL—osteoporosis	4.91e-05	0.00178	CbGpPWpGaD
Dobutamine—COMT—Metabolism—TPI1—osteoporosis	4.85e-05	0.00176	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CYP19A1—osteoporosis	4.75e-05	0.00172	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CALCA—osteoporosis	4.72e-05	0.00171	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CALCA—osteoporosis	4.62e-05	0.00168	CbGpPWpGaD
Dobutamine—COMT—Metabolism—P4HB—osteoporosis	4.56e-05	0.00166	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GAPDH—osteoporosis	4.48e-05	0.00163	CbGpPWpGaD
Dobutamine—COMT—Metabolism—RAP1A—osteoporosis	4.36e-05	0.00158	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ENO1—osteoporosis	4.21e-05	0.00153	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ADCY5—osteoporosis	4.16e-05	0.00151	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PSMA2—osteoporosis	4.15e-05	0.0015	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PSMA5—osteoporosis	4.15e-05	0.0015	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GPX1—osteoporosis	4.14e-05	0.0015	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SOST—osteoporosis	4.13e-05	0.0015	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SOST—osteoporosis	4.04e-05	0.00147	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ADCY5—osteoporosis	3.88e-05	0.00141	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GPX1—osteoporosis	3.87e-05	0.0014	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—MTHFR—osteoporosis	3.82e-05	0.00139	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTH1R—osteoporosis	3.74e-05	0.00136	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CALCR—osteoporosis	3.74e-05	0.00136	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PTH—osteoporosis	3.66e-05	0.00133	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTH1R—osteoporosis	3.65e-05	0.00133	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CALCR—osteoporosis	3.65e-05	0.00133	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PTH—osteoporosis	3.58e-05	0.0013	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—MTHFR—osteoporosis	3.57e-05	0.0013	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CNR2—osteoporosis	3.56e-05	0.00129	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ENO1—osteoporosis	3.53e-05	0.00128	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CNR2—osteoporosis	3.49e-05	0.00127	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PSMA2—osteoporosis	3.47e-05	0.00126	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PSMA5—osteoporosis	3.47e-05	0.00126	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CYP19A1—osteoporosis	3.36e-05	0.00122	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PTH—osteoporosis	3.32e-05	0.00121	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PTH—osteoporosis	3.25e-05	0.00118	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	3.24e-05	0.00118	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CNR2—osteoporosis	3.24e-05	0.00117	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	3.17e-05	0.00115	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CNR2—osteoporosis	3.17e-05	0.00115	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—POMC—osteoporosis	3.06e-05	0.00111	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—WNT1—osteoporosis	3.04e-05	0.0011	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PTHLH—osteoporosis	3.03e-05	0.0011	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—WNT1—osteoporosis	2.98e-05	0.00108	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MGLL—osteoporosis	2.97e-05	0.00108	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PTHLH—osteoporosis	2.96e-05	0.00108	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MGLL—osteoporosis	2.9e-05	0.00105	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LRP5—osteoporosis	2.9e-05	0.00105	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—POMC—osteoporosis	2.85e-05	0.00104	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LRP5—osteoporosis	2.83e-05	0.00103	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYP19A1—osteoporosis	2.82e-05	0.00102	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LRP6—osteoporosis	2.77e-05	0.00101	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PTHLH—osteoporosis	2.75e-05	0.000999	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ADCY5—osteoporosis	2.75e-05	0.000998	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GPX1—osteoporosis	2.74e-05	0.000994	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LRP6—osteoporosis	2.71e-05	0.000984	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PTHLH—osteoporosis	2.69e-05	0.000977	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CALCA—osteoporosis	2.67e-05	0.000968	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CALCA—osteoporosis	2.61e-05	0.000947	CbGpPWpGaD
Dobutamine—CA2—Metabolism—MTHFR—osteoporosis	2.53e-05	0.000917	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—POMC—osteoporosis	2.47e-05	0.000897	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CALCA—osteoporosis	2.42e-05	0.000879	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—POMC—osteoporosis	2.42e-05	0.000877	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CALCA—osteoporosis	2.37e-05	0.00086	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TLN1—osteoporosis	2.34e-05	0.000849	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ADCY5—osteoporosis	2.3e-05	0.000836	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GPX1—osteoporosis	2.3e-05	0.000833	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TLN1—osteoporosis	2.29e-05	0.00083	CbGpPWpGaD
Dobutamine—COMT—Metabolism—MTHFR—osteoporosis	2.12e-05	0.000769	CbGpPWpGaD
Dobutamine—CA2—Metabolism—POMC—osteoporosis	2.02e-05	0.000734	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—P4HB—osteoporosis	2.02e-05	0.000732	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—P4HB—osteoporosis	1.97e-05	0.000716	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTH—osteoporosis	1.96e-05	0.000712	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RAP1A—osteoporosis	1.93e-05	0.0007	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTH—osteoporosis	1.92e-05	0.000697	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CNR2—osteoporosis	1.91e-05	0.000694	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—ADCY5—osteoporosis	1.9e-05	0.000689	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RAP1A—osteoporosis	1.89e-05	0.000685	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NFATC1—osteoporosis	1.88e-05	0.000683	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CNR2—osteoporosis	1.87e-05	0.000679	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DKK1—osteoporosis	1.87e-05	0.000677	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—ADCY5—osteoporosis	1.86e-05	0.000674	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NFATC1—osteoporosis	1.84e-05	0.000668	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DKK1—osteoporosis	1.83e-05	0.000663	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—WNT1—osteoporosis	1.8e-05	0.000652	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—WNT1—osteoporosis	1.76e-05	0.000638	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGA—osteoporosis	1.75e-05	0.000635	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADCY5—osteoporosis	1.72e-05	0.000626	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGA—osteoporosis	1.71e-05	0.000621	CbGpPWpGaD
Dobutamine—COMT—Metabolism—POMC—osteoporosis	1.69e-05	0.000615	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ADCY5—osteoporosis	1.69e-05	0.000612	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BMP2—osteoporosis	1.63e-05	0.00059	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTHLH—osteoporosis	1.63e-05	0.00059	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGB—osteoporosis	1.59e-05	0.000577	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTHLH—osteoporosis	1.59e-05	0.000577	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BMP2—osteoporosis	1.59e-05	0.000577	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGB—osteoporosis	1.56e-05	0.000565	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PSMA2—osteoporosis	1.54e-05	0.000557	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PSMA5—osteoporosis	1.54e-05	0.000557	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PSMA2—osteoporosis	1.5e-05	0.000545	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PSMA5—osteoporosis	1.5e-05	0.000545	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CALCA—osteoporosis	1.43e-05	0.00052	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CALCA—osteoporosis	1.4e-05	0.000508	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—POMC—osteoporosis	1.4e-05	0.000507	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—POMC—osteoporosis	1.37e-05	0.000496	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KL—osteoporosis	1.3e-05	0.000472	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KL—osteoporosis	1.27e-05	0.000461	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—POMC—osteoporosis	1.27e-05	0.00046	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—POMC—osteoporosis	1.24e-05	0.00045	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6R—osteoporosis	1.24e-05	0.000449	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6R—osteoporosis	1.21e-05	0.000439	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADCY5—osteoporosis	1.02e-05	0.00037	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADCY5—osteoporosis	9.96e-06	0.000361	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SPP1—osteoporosis	9.85e-06	0.000358	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SPP1—osteoporosis	9.64e-06	0.00035	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IRS2—osteoporosis	8.91e-06	0.000323	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—LEP—osteoporosis	8.72e-06	0.000316	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IRS2—osteoporosis	8.71e-06	0.000316	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—LEP—osteoporosis	8.53e-06	0.00031	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ESR1—osteoporosis	8.32e-06	0.000302	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ESR1—osteoporosis	8.14e-06	0.000295	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IRS1—osteoporosis	7.78e-06	0.000282	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IRS1—osteoporosis	7.61e-06	0.000276	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—POMC—osteoporosis	7.49e-06	0.000272	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—POMC—osteoporosis	7.33e-06	0.000266	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6R—osteoporosis	7.31e-06	0.000265	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF1—osteoporosis	7.2e-06	0.000261	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6R—osteoporosis	7.15e-06	0.000259	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF1—osteoporosis	7.05e-06	0.000256	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6—osteoporosis	5.51e-06	0.0002	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6—osteoporosis	5.39e-06	0.000196	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MYC—osteoporosis	4.33e-06	0.000157	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TGFB1—osteoporosis	4.32e-06	0.000157	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MYC—osteoporosis	4.23e-06	0.000154	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TGFB1—osteoporosis	4.22e-06	0.000153	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6—osteoporosis	3.25e-06	0.000118	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6—osteoporosis	3.18e-06	0.000116	CbGpPWpGaD
